News | CT Angiography (CTA) | June 25, 2018

Post-Mortem CT Angiography Illuminates Causes of Death

PMCTA detects 90 percent of incidental findings in examination of 500 bodies, while autopsy only finds 61 percent

Post-Mortem CT Angiography Illuminates Causes of Death

June 25, 2018 — Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-mortem diagnosis, according to a study appearing online in the journal Radiology. Researchers said the findings could have important implications for criminal investigations and hospital quality control efforts.

High-quality post-mortem investigations are vital for a number of reasons; most notably, as evidence in criminal investigations for which the body represents the main proof of a crime; and as a quality control measure for surgical interventions and medical treatment at hospitals.

Modern imaging techniques like CT and magnetic resonance imaging (MRI) are often used in forensic pathology. However, post-mortem CT is limited by relatively low soft tissue contrast and poor visualization of the vascular system. A technique known as post-mortem CT angiography (PMCTA) was developed to address those limitations by introducing contrast agent into the body.

“The idea of the PMCTA is to simulate a post-mortem circulation by establishing a post-mortem perfusion of the vascular system,” said study lead author Silke Grabherr, M.D., Ph.D., from the University Center of Legal Medicine Lausanne-Geneva in Lausanne, Switzerland. “Therefore, the heart is ‘replaced’ by a perfusion device, similar to the heart-lung machine that replaces the heart during heart surgery.”

To assess the performance of PMCTA, Grabherr and colleagues at nine centers in Europe performed conventional autopsies on 500 human bodies that had undergone PMCTA. All CT images were read by an experienced team, including one forensic pathologist and one radiologist who were blinded to the autopsy findings.

Autopsy was performed on the day of the PMCTA, or the following day, in all cases. After examination of 500 bodies, a total of 18,654 findings were recorded.

PMCTA performed surprisingly well compared to conventional autopsy. Out of 18,654 total findings, PMCTA found 90 percent, compared with 61 percent for autopsies. PMCTA missed only 10 percent of forensically essential findings, while autopsy missed 23 percent.

“This method could — in many cases — be an alternative to invasive autopsy if such an opening of the body is not possible,” Grabherr said. “This offers new investigation possibilities, for example, in countries where a conventional autopsy is not accepted or in cases where family members can refuse it.”

PMCTA was significantly superior to autopsy at identifying skeletal and vascular lesions, or areas of damage in the bones and blood vessels. PMCTA identified 96 percent of skeletal lesions and 94 percent of vascular lesions, compared with 65 percent for autopsy. These lesions can provide important information in post-mortem examinations, Grabherr said.

“The combination of bone lesions and vascular lesions is especially seen in cases of traumatic death, such as falls from height, traffic accidents, ballistic trauma, and sharp trauma in homicides and suicides,” she said. “This means that PMCTA is an excellent choice to investigate such cases and can be used combined with or even independently of conventional autopsy for investigating in these cases.”

In the future, the research group plans to study the combination of post-mortem angiography with MRI in order to increase the sensitivity of findings related to organs like the brain and liver.

For more information: www.pubs.rsna.org/journal/radiology

 

Reference

Grabherr S., Heinemann A., Vogel H., et al, “Postmortem CT Angiography Compared with Autopsy: A Forensic Multicenter Study.” Radiology, May 1, 2018. https://doi.org/10.1148/radiol.2018170559

Related Content

Philips Healthcare's new Fiber Optic RealShape (FORS) technology creates real-time 3-D imaging of anatomy and devices inside the body using light, rather than X-rays. FORS uses light traveling through hair-thin fiber optics inside special FORS enabled catheter and guidewires.

Philips Healthcare's new Fiber Optic RealShape (FORS) technology creates real-time 3-D imaging of anatomy and devices inside the body using light, rather than X-rays. FORS uses light traveling through hair-thin fiber optics inside special FORS enabled catheter and guidewires. 

Feature | Angiography | March 12, 2020 | Dave Fornell, Editor
Philips is working on a prototype cath lab angiographic imaging system that might be able to replace the current X-ra
he University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the first facility in the United States to install the Artis icono biplane angiography imaging system from Siemens Healthineers.
News | Angiography | February 12, 2020
February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became t
Canon Medical Launches Alphenix Encore Plus Program
News | Angiography | October 09, 2019
In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
Jackson Memorial Hospital Holds Ribbon-cutting for New Cardiac Catheterization Labs
News | Angiography | August 21, 2019
Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during...
Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System
Technology | Angiography | June 24, 2019
Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into...
Medis QAngio XA 3D Receives FDA 510k Clearance
Technology | Angiography | June 04, 2019
Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration for its QAangio XA...
iSchemaView Launches RAPID Angio
Technology | Angiography | March 01, 2019
iSchemaView announced the release of RAPID Angio, a complete neuroimaging solution for the angiography suite that...
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a ...
Canon Medical Debuts Alphenix 4-D CT at RSNA 2018
Technology | Angiography | February 06, 2019
Canon Medical Systems USA Inc. recently introduced a new angiography configuration featuring its Alphenix Sky + C-arm...